The present invention relates to an agent for pancreas protection which contains a combination of a blood glucose lowering drug that does not stimulate insulin secretion and a compound represented by the formula (I)wherein each symbol is defined as in the description, or a salt thereof, or a compound represented by the formula (II)wherein each symbol is defined as in the description,or a salt thereof.